mebanazine
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Monoamine oxidaseINHIBITOR
Monoamine oxidase inhibitor
Mebanazine, a monoamine oxidase inhibitor, when injected in vivo, reduces pituitary weight, STH and LH production, DNA, RNA and alkaline phosphatase activity.
Chemistry & pharmacology
Loading structure…
SMILES
CC(NN)c1ccccc1- Mol. weight
- 136.2 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1909283 ↗
Also known as
- (1-phenylethyl)hydrazine
- actomol
- actomol
- (alpha-methylbenzyl)hydrazine
- ici-31397
- mebanazine
- mebanazine
- mebanazine
- mebanazine
- mebanazine
- mebanazine
- mebanazine
- mebanazine hydrochloride
- mebanazine, (+-)-isomer
- mebanazine monohydrochloride
- mebanazine monohydrochloride, (r)-isomer
- mebanazine monooxalate
- mebanazine monooxalate
- mebanazine monooxalate
- mebanazine monooxalate
- mebanazine monooxalate
- mebanazine monooxalate, (s)-isomer
- mebanazine monosulfate
- mebanazine monosulfate
- mebanazine oxalate
- mebanazine oxalate
- mebanazine oxalate, (+-)-isomer
- mebanazine, (r)-isomer
- mebanazine, (s)-isomer
- mebanazine sulfate
- mebanazine sulfate